One Year Later: Recapping Quality Growth in 2023

Associate Director, Research
01/05/2024

It’s been just over a year since the launch of the WisdomTree U.S. Quality Growth Fund (QGRW) in December 2022.

This year’s performance provided compelling evidence that looking under the hood at the nuances of index construction matters. 

2023 Performance

The WisdomTree U.S. Quality Growth Fund seeks to track the price and yield performance, before fees and expenses, of the WisdomTree U.S. Quality Growth Index (WTQGRW).

The Index was designed to identify stocks that have characteristics of both high profitability and high growth.

Our research into historical returns suggested that investing simply in high-growth stocks can be a losing game over the long run. We believe investors should instead consider investing in high-quality growth stocks.

The U.S. equity market in 2023 was led by these high-quality growth stocks, as evidenced by the outperformance of QGRW relative to other measures of growth and quality.

2023 Total Returns

For the most recent month-end and standardized performance and to download the respective Fund prospectuses, click here.

For definitions of indices in the chart above, please visit the glossary.

The WisdomTree U.S. Quality Growth Index outperformed the Russell 1000 Growth Index by more than 1,000 basis points.

Though more than half of the outperformance was attributed to the tech-focused Information Technology and Communication Services sectors, the Index had positive attribution from 10 of 11 sectors.

2023 Index Attribution: WisdomTree U.S. Quality Growth vs. Russell 1000 Growth

2023 Total Returns chart

Semi-Annual Index Rebalance

The Index rebalances each June and December. The universe of eligible securities is ranked on quality and growth factors separately, with the 100 highest-scoring securities selected.

At this December’s rebalance, the only changes to the top 10 holdings were the addition of Broadcom at a roughly 3% weight, offset by the drop of UnitedHealth Group, which had held a 3.3% weight.

The remaining nine holdings were unchanged from the rebalance.

WisdomTree U.S. Quality Growth Index Top 10 Holdings

WisdomTree U.S. Quality Growth Index Top 10 Holdings tsble as of 12/13/23.

Of the 100 securities held in the pre-rebalance Index, 79 were maintained, and 21 were dropped/added. The cumulative impact on one-way Index turnover was 16%.

Holdings Overlap and Turnover for the WisdomTree U.S. Quality Growth Index

Sector changes were modest. The impact of the drop of UnitedHealth can be seen in a lower weight in Health Care, offset by an increase in Information Technology driven by the addition of Broadcom.

Sector Changes: WisdomTree U.S. Quality Growth Index

Sector Changes: WisdomTree U.S. Quality Growth Index chart as of 12/13/23

At each semi-annual rebalance, the Index systematically refreshes exposure to these high-quality and growth characteristics. This can be seen by the significant improvements in profitability and growth characteristics compared to the S&P 500.

For example, the return on assets (ROA) for the Index is more than twice that of the S&P 500 while also having a trailing five-year sales growth of almost 7 percentage points higher.

Index Characteristics

Index Characteristics table as of 12/13/23.

For definitions of terms in the table above, please visit the glossary.

Building a Quality Portfolio

The WisdomTree U.S. Quality Dividend Growth Fund (DGRW) was WisdomTree’s first quality fund launched in 2013. 

The Fund invests in high-quality dividend-paying companies, creating a more value-tilted core allocation. As a byproduct of its dividend requirement, the Fund is under-weight in many of the non-dividend-paying mega-cap companies that are top holdings in QGRW.

For investors utilizing an allocation to DGRW or a similar value-tilted core allocation under-weight in some of the non-dividend-paying mega-caps, a blend of DGRW with QGRW may mitigate some of the under-weights in the portfolio.

S&P 500 Top 10 Holdings

S&P 500 Top 10 Holdings table as of 12/13/23

Important Risks Related to this Article

QGRW: There are risks associated with investing, including the possible loss of principal. Growth stocks, as a group, may be out of favor with the market and underperform value stocks or the overall equity market. Growth stocks are generally more sensitive to market movements than other types of stocks. The Fund is non-diversified; as a result, changes in the market value of a single security could cause greater fluctuations in the value of Fund shares than would occur in a diversified fund. The Fund invests in the securities included in, or representative of, its Index regardless of their investment merit. The Fund does not attempt to outperform its Index or take defensive positions in declining markets, and the Index may not perform as intended. Please read the Fund’s prospectus for specific details regarding the Fund’s risk profile.

DGRW: There are risks associated with investing, including the possible loss of principal. Funds focusing their investments on certain sectors increase their vulnerability to any single economic or regulatory development. This may result in greater share price volatility. Dividends are not guaranteed, and a company currently paying dividends may cease paying dividends at any time. Please read the Fund’s prospectus for specific details regarding the Fund’s risk profile.

Related Funds

WisdomTree U.S. Quality Growth Fund

WisdomTree U.S. Quality Dividend Growth Fund

For more investing insights, check out our Economic & Market Outlook

Tags

About the Contributor
Associate Director, Research
Matt Wagner joined WisdomTree in May 2017 as an Analyst on the Research team. In his current role as an Associate Director, he supports the creation, maintenance, and reconstitution of our indexes and actively managed ETFs. Matt started his career at Morgan Stanley, working as an analyst in Treasury Capital Markets from 2015 to 2017 where he focused on unsecured funding planning, execution and risk management. Matt graduated from Boston College in 2015 with a B.A. in International Studies with a concentration in Economics. In 2020, he earned a Certificate in Advanced Valuation from NYU Stern. Matt is a holder of the Chartered Financial Analyst designation.